FCGR3B and chronic obstructive pulmonary disease: FCGR3B deletion has previously been associated with several autoimmune disorders39–41; in this study, decreasing FCGR3B gene dosage was also associated with an increasing risk of chronic obstructive pulmonary disease (P = 7.5 × 10−7; Fig. 5d and Supplementary Table 6c).